Several gene expression studies demonstrated an increase in EZH2 expression during MM development from MGUS and SMM reaching its maximum at the PCL stage (Figure 1), suggesting disease progression-related functions of EZH2. Here, EZH2 is linked to Miyoshi myopathy.